APA استشهاد

Araki, R., Nishimura, R., Inaki, A., Wakabayashi, H., Imai, Y., Kuribayashi, Y., . . . Kinuya, S. (2018). Feasibility of High-dose Iodine-131-metaiodobenzylguanidine Therapy for High-risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: A Study Protocol. Asia Ocean J Nucl Med Biol.

استشهاد بنمط شيكاغو

Araki, Raita, Ryosei Nishimura, Anri Inaki, Hiroshi Wakabayashi, Yasuhito Imai, Yoshikazu Kuribayashi, Kenichi Yoshimura, Toshinori Murayama, و Seigo Kinuya. "Feasibility of High-dose Iodine-131-metaiodobenzylguanidine Therapy for High-risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: A Study Protocol." Asia Ocean J Nucl Med Biol 2018.

MLA استشهاد

Araki, Raita, et al. "Feasibility of High-dose Iodine-131-metaiodobenzylguanidine Therapy for High-risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: A Study Protocol." Asia Ocean J Nucl Med Biol 2018.

تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.